col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


127 Results       Page 1

 [1] 
The Royal Society of Chemistry: RSC Advances
  original article Date Title Authors   All Authors
1 [GO] 2023―May―19 Development of high affinity broadly reactive aptamers for spike protein of multiple SARS-CoV-2 variants Thao T. Le, Donald J. Benton, Antoni G. Wrobel, Steven J. Gamblin
2 [GO] 2023―Apr―20 Implication of nanotechnology to reduce the environmental risks of waste associated with the COVID-19 pandemic Gharieb S. El-Sayyad, Dounia Elfadil, Mohamed S. Gaballah, Dina M. El-Sherif, Mohamed Abouzid, Hanady G. Nada, et al. (+2)
3 [GO] 2023―Apr―12 Efficient dispersive solid-phase extraction of methylprednisolone from exhaled breath of COVID-19 patients Yasaman Sefid-Sefidehkhan, Mehdi Mokhtari, Ata Mahmoodpoor, Yosra Vaez-Gharamaleki, Maryam Khoubnasabjafari, Mohammad Reza Afshar Moghaddam, et al. (+4)
4 [GO] 2023―Apr―04 A covalent inhibitor targeting the papain-like protease from SARS-CoV-2 inhibits viral replication Hesong Han, Albert Vallejo Gracia, Joachim J. Røise, Lydia Boike, Kristoffer Leon, Ursula Schulze-Gahmen, et al. (+12)
5 [GO] 2023―Mar―28 The influence of single-point mutation D614G on the binding process between human angiotensin-converting enzyme 2 and the SARS-CoV-2 spike protein-an atomistic simulation study Chengcheng Shi, Yanqi Jiao, Chao Yang, Yao Sun
6 [GO] 2023―Mar―20 Dimerized fusion inhibitor peptides targeting the HR1-HR2 interaction of SARS-CoV-2 Kohei Tsuji, Kofi Baffour-Awuah Owusu, Yutaro Miura, Takahiro Ishii, Kouki Shinohara, Takuya Kobayakawa, et al. (+4)
7 [GO] 2023―Feb―16 CeO2@NH2 functionalized electrodes for the rapid detection of SARS-CoV-2 spike receptor binding domain Ayu Triastuti, Salma Nur Zakiyyah, Shabarni Gaffar, Isa Anshori, Akhmadi Surawijaya, Darmawan Hidayat, et al. (+3)
8 [GO] 2023―Jan―26 Recent updates on the biological efficacy of approved drugs and potent synthetic compounds against SARS-CoV-2 Sumit Kumar, Brijesh Rathi
9 [GO] 2022―Dec―15 Correction: Rapid prediction of possible inhibitors for SARS-CoV-2 main protease using docking and FPL simulations Minh Quan Pham, Khanh B. Vu, T. Ngoc Han Pham, Le Thi Thuy Huong, Linh Hoang Tran, Nguyen Thanh Tung, et al. (+3)
10 [GO] 2022―Dec―06 Two-stage one-pot synthetic strategy for the key triazone-triazole intermediate of ensitrelvir (S-217622), an oral clinical candidate for treating COVID-19 Wei Hu, Xiang Zhang, Yuanchang Liu, Teng Liu, Jiale Wen, Xiaopeng Peng, et al. (+2)
11 [GO] 2022―Nov―16 Evaluation of antiviral activity of Carica papaya leaves against SARS-CoV-2 assisted by metabolomic profiling Amr Adel, Mohamed S. Elnaggar, Amgad Albohy, Ahmed A. Elrashedy, Ahmed Mostafa, Omnia Kutkat, et al. (+3)
12 [GO] 2022―Nov―04 Nanotechnology meets immunology towards a rapid diagnosis solution: the COVID-19 outbreak challenge Santos B. S. A. S., Cunha J. L. R., Carvalho I. C., Costa J. M. C., Longo B. C., Galinari G. C. F., et al. (+9)
13 [GO] 2022―Nov―02 Correction: The role of electrochemical biosensors in SARS-CoV-2 detection: a bibliometrics-based analysis and review Shuduan Mao, Li Fu, Chengliang Yin, Xiaozhu Liu, Hassan Karimi-Maleh
14 [GO] 2022―Sep―22 In vitro and computational investigations of novel synthetic carboxamide-linked pyridopyrrolopyrimidines with potent activity as SARS-CoV-2-MPro inhibitors Ateyatallah Aljuhani, Hany E. A. Ahmed, Saleh K. Ihmaid, Abdelsattar M. Omar, Sultan S. Althagfan, Yaser M. Alahmadi, et al. (+12)
15 [GO] 2022―Aug―31 Salivary SARS-CoV-2 antibody detection using S1-RBD protein-immobilized 3D melt electrowritten poly(ε-caprolactone) scaffolds Pingping Han, Chun Liu, Reuben Staples, Corey S. Moran, Srinivas Sulugodu Ramachandra, Maria Natividad Gómez-Cerezo, Sašo Ivanovski
16 [GO] 2022―Aug―12 The role of electrochemical biosensors in SARS-CoV-2 detection: a bibliometrics-based analysis and review Shudan Mao, Li Fu, Chengliang Yin, Xiaozhu Liu, Hassan Karimi-Maleh
17 [GO] 2022―Aug―11 Remdesivir analog as SARS-CoV-2 polymerase inhibitor: virtual screening of a database generated by scaffold replacement Mohamed A. Said, Amgad Albohy, Mohamed A. Abdelrahman, Hany S. Ibarhim
18 [GO] 2022―Aug―09 Utility of a novel turn-off fluorescence probe for the determination of tranilast, an adjunctive drug for patients with severe COVID-19 Diaa Dagher, Heba Elmansi, Jenny Jeehan Nasr, Nahed El-Enany
19 [GO] 2022―Jul―08 Synthesis of pyrazolo[5′,1′:2,3]imidazo[1,5-c]quinazolin-6(5H)-ones and molecular docking study of their affinity against the COVID-19 main protease Shaghayegh Saeedi, Abbas Rahmati, Zahra Chavoshpour-Natanzi
20 [GO] 2022―Jul―06 Secondary metabolites of Livistona decipiens as potential inhibitors of SARS-CoV-2 Seham S. El-hawary, Taha F. S. Ali, Sara O. Abo El-Ela, Ahlam Elwekeel, Usama Ramadan Abdelmohsen, Asmaa I. Owis
21 [GO] 2022―Jun―22 In vitro and in silico studies of SARS-CoV-2 main protease Mpro inhibitors isolated from Helichrysum bracteatum Gehad Abdel Wahab, Walaa S. Aboelmaaty, Mohamed Farid Lahloub, Amal Sallam
22 [GO] 2022―Jun―22 A SARS-Cov-2 sensor based on upconversion nanoparticles and graphene oxide Konstantina Alexaki, Maria Eleni Kyriazi, Joshua Greening, Lapatrada Taemaitree, Afaf H. El-Sagheer, Tom Brown, et al. (+3)
23 [GO] 2022―Jun―06 Fabrication of novel quantum dots for the estimation of COVID-19 antiviral drug using green chemistry: application to real human plasma Baher I. Salman, Adel Ehab Ibrahim, Sami El Deeb, Roshdy E. Saraya
24 [GO] 2022―May―31 Inhibition of SARS-CoV-2 spike protein entry using biologically modified polyacrylonitrile nanofibers: in vitro study towards specific antiviral masks Merna H. Emam, Hassan Nageh, Fedaa Ali, Mohamed Taha, Hasnaa A. ElShehaby, Rehab Amin, et al. (+3)
25 [GO] 2022―May―27 Pyrazolone-type compounds: synthesis and in silico assessment of antiviral potential against key viral proteins of SARS-CoV-2 Jovica Branković, Vesna M. Milovanović, Dušica Simijonović, Slađana Novaković, Zorica D. Petrović, Snežana S. Trifunović, et al. (+2)
26 [GO] 2022―May―25 Antiviral activity of chitosan nanoparticles encapsulating silymarin (Sil-CNPs) against SARS-CoV-2 (in silico and in vitro study) Samah A. Loutfy, Ahmed I. Abdel-Salam, Yassmin Moatasim, Mokhtar R. Gomaa, Nasra F. Abdel Fattah, Merna H. Emam, et al. (+7)
27 [GO] 2022―May―11 A new insight into the transfer and delivery of anti-SARS-CoV-2 drug Carmofur with the assistance of graphene oxide quantum dot as a highly efficient nanovector toward COVID-19 by molecular dynamics simulation Mahnaz Shahabi, Heidar Raissi
28 [GO] 2022―May―06 Green aspects of photocatalysts during corona pandemic: a promising role for the deactivation of COVID-19 virus Abhinandan Kumar, Vatika Soni, Pardeep Singh, Aftab Aslam Parwaz Khan, Mohammed Nazim, Satyabrata Mohapatra, et al. (+6)
29 [GO] 2022―Mar―28 Rapid diagnosis of COVID-19 via nano-biosensor-implemented biomedical utilization: a systematic review Mohammad Harun-Ur-Rashid, Tahmina Foyez, Israt Jahan, Kaushik Pal, Abu Bin Imran
30 [GO] 2022―Mar―25 Cold atmospheric pressure plasma for attenuation of SARS-CoV-2 spike protein binding to ACE2 protein and the RNA deactivation Rakesh Ruchel Khanikar, Monalisa Kalita, Parismita Kalita, Bhaswati Kashyap, Santanu Das, Mojibur R. Khan, et al. (+2)
31 [GO] 2022―Mar―23 Gate-all-around junctionless FET based label-free dielectric/charge modulation detection of SARS-CoV-2 virus Kumari Nibha Priyadarshani, Sangeeta Singh, Mustafa K. A. Mohammed
32 [GO] 2022―Mar―10 Bioactive phytoconstituents as potent inhibitors of casein kinase-2: dual implications in cancer and COVID-19 therapeutics Farah Anjum, Md Nayab Sulaimani, Alaa Shafie, Taj Mohammad, Ghulam Md. Ashraf, Anwar L. Bilgrami, et al. (+4)
33 [GO] 2022―Feb―16 Mitoxantrone dihydrochloride, an FDA approved drug, binds with SARS-CoV-2 NSP1 C-terminal Prateek Kumar, Taniya Bhardwaj, Rajanish Giri
34 [GO] 2022―Feb―14 Exploration of plant-derived natural polyphenols toward COVID-19 main protease inhibitors: DFT, molecular docking approach, and molecular dynamics simulations Yufei Ma, Yulian Tao, Hanyang Qu, Cuihong Wang, Fei Yan, Xiujun Gao, Meiling Zhang
35 [GO] 2022―Feb―02 Design of a multi-epitope vaccine against SARS-CoV-2: immunoinformatic and computational methods Md. Oliullah Rafi, Khattab Al-Khafaji, Md. Takim Sarker, Tugba Taskin-Tok, Abdus Samad Rana, Md. Shahedur Rahman
36 [GO] 2022―Jan―28 Insights into the binding and covalent inhibition mechanism of PF-07321332 to SARS-CoV-2 Mpro Son Tung Ngo, Trung Hai Nguyen, Nguyen Thanh Tung, Binh Khanh Mai
37 [GO] 2022―Jan―28 Antiviral activities of natural compounds and ionic liquids to inhibit the Mpro of SARS-CoV-2: a computational approach Kandhan Palanisamy, S. M. Esther Rubavathy, Muthuramalingam Prakash, Ramasamy Thilagavathi, Maryam S. Hosseini-Zare, Chelliah Selvam
38 [GO] 2022―Jan―25 A rapid water bath PCR combined with lateral flow assay for the simultaneous detection of SARS-CoV-2 and influenza B virus Hong Chen, Yunxiang Wang, Hongjuan Wei, Zhen Rong, Shengqi Wang
39 [GO] 2022―Jan―20 Molecular dynamics simulations and MM-GBSA reveal novel guanosine derivatives against SARS-CoV-2 RNA dependent RNA polymerase Abdo A. Elfiky, Hanan A. Mahran, Ibrahim M. Ibrahim, Mohamed N. Ibrahim, Wael M. Elshemey
40 [GO] 2021―Dec―17 GC-MS analysis of phytoconstituents from Ruellia prostrata and Senna tora and identification of potential anti-viral activity against SARS-CoV-2 Rahat Alam, Raihan Rahman Imon, Md. Enamul Kabir Talukder, Shahina Akhter, Md. Alam Hossain, Foysal Ahammad, Md. Mashiar Rahman
41 [GO] 2021―Dec―10 The dolabellane diterpenes as potential inhibitors of the SARS-CoV-2 main protease: molecular insight of the inhibitory mechanism through computational studies Nanik Siti Aminah, Muhammad Ikhlas Abdjan, Andika Pramudya Wardana, Alfinda Novi Kristanti, Imam Siswanto, Khusna Arif Rakhman, Yoshiaki Takaya
42 [GO] 2021―Dec―10 Design, synthesis and in silico screening of benzoxazole-thiazolidinone hybrids as potential inhibitors of SARS-CoV-2 proteases Vijay Sai Krishna Cheerala, Prasanth Ghanta, Sundaresan Chittor Neelakantan
43 [GO] 2021―Dec―03 Whole genome sequencing for revealing the point mutations of SARS-CoV-2 genome in Bangladeshi isolates and their structural effects on viral proteins Mohammad Uzzal Hossain, Ishtiaque Ahammad, Arittra Bhattacharjee, Zeshan Mahmud Chowdhury, Md. Tabassum Hossain Emon, Keshob Chandra Das, et al. (+2)
44 [GO] 2021―Dec―01 In silico analysis of SARS-CoV-2 papain-like protease potential inhibitors Samia A. Elseginy, Manal M. Anwar
45 [GO] 2021―Nov―29 Searching and designing potential inhibitors for SARS-CoV-2 Mpro from natural sources using atomistic and deep-learning calculations Nguyen Minh Tam, Duc-Hung Pham, Dinh Minh Hiep, Phuong-Thao Tran, Duong Tuan Quang, Son Tung Ngo
46 [GO] 2021―Nov―18 Identifying the specific-targeted marine cerebrosides against SARS-CoV-2: an integrated computational approach Eman Maher Zahran, Ahmed M. Sayed, Miada F. Abdelwahab, Amgad Albohy, Basma S. Abdulrazik, Ayman M. Ibrahim, et al. (+2)
47 [GO] 2021―Nov―10 Computational methods directed towards drug repurposing for COVID-19: advantages and limitations Prem Prakash Sharma, Meenakshi Bansal, Aaftaab Sethi, Lindomar Pena, Vijay Kumar Goel, Maria Grishina, et al. (+3)
48 [GO] 2021―Nov―10 Determination of sodium and potassium ions in patients with SARS-Cov-2 disease by ion-selective electrodes based on polyelectrolyte complexes as a pseudo-liquid contact phase Liubov V. Pershina, Andrei R. Grabeklis, Ludmila N. Isankina, Ekaterina V. Skorb, Konstantin G. Nikolaev
49 [GO] 2021―Nov―03 β-Blockers bearing hydroxyethylamine and hydroxyethylene as potential SARS-CoV-2 Mpro inhibitors: rational based design, in silico, in vitro, and SAR studies for lead optimization Mohammed I. A. Hamed, Khaled M. Darwish, Raya Soltane, Amani Chrouda, Ahmed Mostafa, Noura M. Abo Shama, et al. (+5)
50 [GO] 2021―Nov―01 Theoretical insights into the effect of halogenated substituent on the electronic structure and spectroscopic properties of the favipiravir tautomeric forms and its implications for the treatment of COVID-19 Letícia Cristina Assis, Alexandre Alves de Castro, João Paulo Almirão de Jesus, Elaine Fontes Ferreira da Cunha, Eugenie Nepovimova, Ondrej Krejcar, et al. (+3)
51 [GO] 2021―Oct―25 A label-free graphene-based impedimetric biosensor for real-time tracing of the cytokine storm in blood serum; suitable for screening COVID-19 patients Mohammad Ali Khayamian, Mohammad Salemizadeh Parizi, Mohammadreza Ghaderinia, Hamed Abadijoo, Shohreh Vanaei, Hossein Simaee, et al. (+8)
52 [GO] 2021―Oct―14 Thermodynamics and kinetics in antibody resistance of the 501Y.V2 SARS-CoV-2 variant Son Tung Ngo, Trung Hai Nguyen, Duc-Hung Pham, Nguyen Thanh Tung, Pham Cam Nam
53 [GO] 2021―Oct―13 Dietary stigmastane-type saponins as promising dual-target directed inhibitors of SARS-CoV-2 proteases: a structure-based screening Oludare M. Ogunyemi, Gideon A. Gyebi, Ibrahim M. Ibrahim, Charles O. Olaiya, Joshua O. Ocheje, Modupe M. Fabusiwa, Joseph O. Adebayo
54 [GO] 2021―Sep―30 Chemical constituents from Limonium tubiflorum and their in silico evaluation as potential antiviral agents against SARS-CoV-2 Ahmed R. Hassan, Ibrahim M. Sanad, Ahmed E. Allam, Mohamed E. Abouelela, Ahmed M. Sayed, Shalabia S. Emam, et al. (+2)
55 [GO] 2021―Sep―22 Newly designed analogues from SARS-CoV inhibitors mimicking the druggable properties against SARS-CoV-2 and its novel variants Nadim Ferdous, Mahjerin Nasrin Reza, Md. Shariful Islam, Md. Tabassum Hossain Emon, A. K. M. Mohiuddin, Mohammad Uzzal Hossain
56 [GO] 2021―Sep―22 Investigating the structure-activity relationship of marine natural polyketides as promising SARS-CoV-2 main protease inhibitors Amr El-Demerdash, Ahmed A. Al-Karmalawy, Tarek Mohamed Abdel-Aziz, Sameh S. Elhady, Khaled M. Darwish, Ahmed H. E. Hassan
57 [GO] 2021―Sep―16 Bis-indolylation of aldehydes and ketones using silica-supported FeCl3: molecular docking studies of bisindoles by targeting SARS-CoV-2 main protease binding sites Barnali Deb, Sudhan Debnath, Ankita Chakraborty, Swapan Majumdar
58 [GO] 2021―Sep―09 The SARS-CoV-2 B.1.618 variant slightly alters the spike RBD-ACE2 binding affinity and is an antibody escaping variant: a computational structural perspective Abbas Khan, Jianjun Gui, Waqar Ahmad, Inamul Haq, Marukh Shahid, Awais Ahmed Khan, et al. (+10)
59 [GO] 2021―Sep―02 Comparative assessment of RNA-dependent RNA polymerase (RdRp) inhibitors under clinical trials to control SARS-CoV2 using rigorous computational workflow Dweipayan Goswami
60 [GO] 2021―Aug―03 In silico study of the inhibition of SARS-COV-2 viral cell entry by neem tree extracts Daniel M. Shadrack, Said A. H. Vuai, Mtabazi G. Sahini, Isaac Onoka
61 [GO] 2021―Aug―02 Nanomaterial-based drug delivery systems as promising carriers for patients with COVID-19 M. Abd Elkodous, S. O. Olojede, Mahmoud Morsi, Gharieb S. El-Sayyad
62 [GO] 2021―Jul―26 Detection of SARS-CoV-2 and its S and N proteins using surface enhanced Raman spectroscopy John Eder Sanchez, Sierra A. Jaramillo, Erik Settles, J. Jesus Velazquez Salazar, Alexander Lehr, Javier Gonzalez, et al. (+9)
63 [GO] 2021―Jul―02 Drug repurposing and computational modeling for discovery of inhibitors of the main protease (Mpro) of SARS-CoV-2 José Rogério A. Silva, Hendrik G. Kruger, Fábio A. Molfetta
64 [GO] 2021―Jun―24 In silico study of natural compounds from sesame against COVID-19 by targeting Mpro, PLpro and RdRp Ahmed E. Allam, Yhiya Amen, Ahmed Ashour, Hamdy K. Assaf, Heba Ali Hassan, Islam M. Abdel-Rahman, et al. (+2)
65 [GO] 2021―Jun―23 Potential inhibitors for SARS-CoV-2 Mpro from marine compounds Nguyen Minh Tam, Minh Quan Pham, Huy Truong Nguyen, Nam Dao Hong, Nguyen Khoa Hien, Duong Tuan Quang, et al. (+2)
66 [GO] 2021―Jun―09 A comprehensive overview of vaccines developed for pandemic viral pathogens over the past two decades including those in clinical trials for the current novel SARS-CoV-2 Kannan Damodharan, Gandarvakottai Senthilkumar Arumugam, Suresh Ganesan, Mukesh Doble, Sathiah Thennarasu
67 [GO] 2021―Jun―04 Two novel oxetane containing lignans and a new megastigmane from Paronychia arabica and in silico analysis of them as prospective SARS-CoV-2 inhibitors Abdelsamed I. Elshamy, Tarik A. Mohamed, Mahmoud A. A. Ibrahim, Mohamed A. M. Atia, Tatsuro Yoneyama, Akemi Umeyama, Mohamed-Elamir F. Hegazy
68 [GO] 2021―May―28 3D printed chitosan/polycaprolactone scaffold for lung tissue engineering: hope to be useful for COVID-19 studies Farnoush Sadat Rezaei, Ayeh Khorshidian, Farzaneh Mahmoudi Beram, Atefeh Derakhshani, Javad Esmaeili, Aboulfazl Barati
69 [GO] 2021―May―19 Immunoinformatics-guided design of a multi-epitope vaccine based on the structural proteins of severe acute respiratory syndrome coronavirus 2 Ahmad J. Obaidullah, Mohammed M. Alanazi, Nawaf A. Alsaif, Hussam Albassam, Abdulrahman A. Almehizia, Ali M. Alqahtani, et al. (+3)
70 [GO] 2021―May―12 A review on potential of natural products in the management of COVID-19 Rudra Chakravarti, Rajveer Singh, Arijit Ghosh, Dhritiman Dey, Priyanka Sharma, Ravichandiran Velayutham, et al. (+2)
71 [GO] 2021―May―12 Computational estimation of potential inhibitors from known drugs against the main protease of SARS-CoV-2 Nguyen Minh Tam, Minh Quan Pham, Nguyen Xuan Ha, Pham Cam Nam, Huong Thi Thu Phung
72 [GO] 2021―May―10 Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay Ting Xue, Weikun Wu, Ning Guo, Chengyong Wu, Jian Huang, Lipeng Lai, et al. (+4)
73 [GO] 2021―May―05 Latin American databases of natural products: biodiversity and drug discovery against SARS-CoV-2 Marvin J. Núñez, Bárbara I. Díaz-Eufracio, José L. Medina-Franco, Dionisio A. Olmedo
74 [GO] 2021―Apr―12 Flavonoids of Salvadora persica L. (meswak) and its liposomal formulation as a potential inhibitor of SARS-CoV-2 Asmaa I. Owis, Marwa S. El-Hawary, Dalia El Amir, Hesham Refaat, Eman Alaaeldin, Omar M. Aly, et al. (+2)
75 [GO] 2021―Apr―07 Identification of (2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3-yl-3,4,5-trihydroxy benzoate as multiple inhibitors of SARS-CoV-2 targets; a systematic molecular modelling approach Jubie Selvaraj, Shyam Sundar P, Logesh Rajan, Divakar Selvaraj, Dhanabal Palanisamy, Krishnan Namboori PK, Suresh Kumar Mohankumar
76 [GO] 2021―Mar―25 The inhibition of Mpro, the primary protease of COVID-19, by Poria cocos and its active compounds: a network pharmacology and molecular docking study Zhimin Wu, Xiaoxue Chen, Weiju Ni, Danshui Zhou, Shanshan Chai, Weile Ye, et al. (+4)
77 [GO] 2021―Mar―24 A phytochemical-based medication search for the SARS-CoV-2 infection by molecular docking models towards spike glycoproteins and main proteases Anju Choorakottayil Pushkaran, Prajeesh Nath EN, Anu R. Melge, Rammanohar Puthiyedath, C. Gopi Mohan
78 [GO] 2021―Mar―09 Revisiting activity of some glucocorticoids as a potential inhibitor of SARS-CoV-2 main protease: theoretical study Ayman Abo Elmaaty, Radwan Alnajjar, Mohammed I. A. Hamed, Muhammad Khattab, Mohamed M. Khalifa, Ahmed A. Al-Karmalawy
79 [GO] 2021―Feb―25 Insight into the origin of SARS-CoV-2 through structural analysis of receptor recognition: a molecular simulation study Jixue Sun, Meijiang Liu, Na Yang
80 [GO] 2021―Feb―08 A comprehensive review on antimicrobial face masks: an emerging weapon in fighting pandemics Gayathri Pullangott, Uthradevi Kannan, Gayathri S., Degala Venkata Kiran, Shihabudheen M. Maliyekkal
81 [GO] 2021―Feb―02 Carbon nanotubes for rapid capturing of SARS-COV-2 virus: revealing a mechanistic aspect of binding based on computational studies Shivkumar Patel, Amit Kumar Srivastav, Sanjeev K. Gupta, Umesh Kumar, S. K. Mahapatra, P. N. Gajjar, I. Banerjee
82 [GO] 2021―Jan―27 Combination of system biology to probe the anti-viral activity of andrographolide and its derivative against COVID-19 Pukar Khanal, Yadu Nandan Dey, Rajesh Patil, Rupesh Chikhale, Manish M. Wanjari, Shailendra S. Gurav, et al. (+3)
83 [GO] 2021―Jan―22 Ligand-based design, molecular dynamics and ADMET studies of suggested SARS-CoV-2 Mpro inhibitors Nada M. Mohamed, Eslam M. H. Ali, Asmaa M. AboulMagd
84 [GO] 2021―Jan―19 In silico design of peptides with binding to the receptor binding domain (RBD) of the SARS-CoV-2 and their utility in bio-sensor development for SARS-CoV-2 detection Yogesh Badhe, Rakesh Gupta, Beena Rai
85 [GO] 2021―Jan―15 Correction: The inactivation mechanism of chemical disinfection against SARS-CoV-2: from MD and DFT perspectives Chunjian Tan, Chenshan Gao, Quan Zhou, Willem Van Driel, Huaiyu Ye, Guoqi Zhang
86 [GO] 2021―Jan―14 Interaction analyses of SARS-CoV-2 spike protein based on fragment molecular orbital calculations Kazuki Akisawa, Ryo Hatada, Koji Okuwaki, Yuji Mochizuki, Kaori Fukuzawa, Yuto Komeiji, Shigenori Tanaka
87 [GO] 2021―Jan―13 Binding of inhibitors to the monomeric and dimeric SARS-CoV-2 Mpro Nguyen Minh Tam, Pham Cam Nam, Duong Tuan Quang, Nguyen Thanh Tung, Van V. Vu, Son Tung Ngo
88 [GO] 2021―Jan―13 Inhibitory activity of quercetin, its metabolite, and standard antiviral drugs towards enzymes essential for SARS-CoV-2: the role of acid-base equilibria Žiko B. Milanović, Marko R. Antonijević, Ana D. Amić, Edina H. Avdović, Dušan S. Dimić, Dejan A. Milenković, Zoran S. Marković
89 [GO] 2021―Jan―04 Immune response and possible therapeutics in COVID-19 Anindya Dutta, Ananya Roy, Laboni Roy, Samit Chattopadhyay, Subhrangsu Chatterjee
90 [GO] 2020―Dec―14 Interpretation of SARS-CoV-2 behaviour on different substrates and denaturation of virions using ethanol: an atomic force microscopy study Umit Celik, Kubra Celik, Suleyman Celik, Hasan Abayli, Kezban Can Sahna, Şükrü Tonbak, et al. (+2)
91 [GO] 2020―Dec―07 1-Phenyl-N-(benzothiazol-2-yl)methanimine derivatives as Middle East respiratory syndrome coronavirus inhibitors Min-Qi Hu, Heng Li, Ying Lin, Ying Zhang, Jie Tang, Jian-Ping Zuo, et al. (+4)
92 [GO] 2020―Nov―26 In silico identification of SARS-CoV-2 spike (S) protein-ACE2 complex inhibitors from eight Tecoma species and cultivars analyzed by LC-MS Seham S. El Hawary, Amira R. Khattab, Hanan S. Marzouk, Amira S. El Senousy, Mariam G. A. Alex, Omar M. Aly, et al. (+2)
93 [GO] 2020―Nov―25 Correction: Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 Mpro Vishal M. Balaramnavar, Khurshid Ahmad, Mohd Saeed, Irfan Ahmad, Mehnaz Kamal, Talha Jawaid
94 [GO] 2020―Nov―10 Accelerating the repurposing of FDA-approved drugs against coronavirus disease-19 (COVID-19) Simona De Vita, Maria Giovanna Chini, Gianluigi Lauro, Giuseppe Bifulco
95 [GO] 2020―Nov―09 Assessing potential inhibitors of SARS-CoV-2 main protease from available drugs using free energy perturbation simulations Son Tung Ngo, Hung Minh Nguyen, Le Thi Thuy Huong, Pham Minh Quan, Vi Khanh Truong, Nguyen Thanh Tung, Van V. Vu
96 [GO] 2020―Nov―06 The inactivation mechanism of chemical disinfection against SARS-CoV-2: from MD and DFT perspectives Chunjian Tan, Chenshan Gao, Quan Zhou, Willem Van Driel, Huaiyu Ye, Guoqi Zhang
97 [GO] 2020―Nov―04 Antiviral agents against COVID-19: structure-based design of specific peptidomimetic inhibitors of SARS-CoV-2 main protease Vladimir Frecer, Stanislav Miertus
98 [GO] 2020―Nov―04 Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 Mpro Vishal M. Balaramnavar, Khurshid Ahmad, Mohd Saeed, Irfan Ahmad, Mehnaz Kamal, Talaha Jawed
99 [GO] 2020―Nov―02 Amino acid interacting network in the receptor-binding domain of SARS-CoV-2 spike protein Puja Adhikari, Wai-Yim Ching
100 [GO] 2020―Nov―01 ACE2 as a potential therapeutic target for pandemic COVID-19 Bhaswati Chatterjee, Suman S. Thakur
101 [GO] 2020―Oct―15 Anti-inflammatory, antiallergic and COVID-19 protease inhibitory activities of phytochemicals from the Jordanian hawksbeard: identification, structure-activity relationships, molecular modeling and impact on its folk medicinal uses Sherif S. Ebada, Nariman A. Al-Jawabri, Fadia S. Youssef, Dina H. El-Kashef, Tim-Oliver Knedel, Amgad Albohy, et al. (+9)
102 [GO] 2020―Oct―13 Ilimaquinone (marine sponge metabolite) as a novel inhibitor of SARS-CoV-2 key target proteins in comparison with suggested COVID-19 drugs: designing, docking and molecular dynamics simulation study Malvi Surti, Mitesh Patel, Mohd Adnan, Afrasim Moin, Syed Amir Ashraf, Arif Jamal Siddiqui, et al. (+3)
103 [GO] 2020―Sep―30 Design and optimization of a subunit vaccine targeting COVID-19 molecular shreds using an immunoinformatics framework Neeraj Kumar, Damini Sood, Ramesh Chandra
104 [GO] 2020―Sep―23 Diagnostic technologies for COVID-19: a review Qi Chen, Zhenyun He, Fujing Mao, Hua Pei, Hongmei Cao, Xing Liu
105 [GO] 2020―Sep―23 Several coumarin derivatives and their Pd(ii) complexes as potential inhibitors of the main protease of SARS-CoV-2, an in silico approach Dejan A. Milenković, Dušan S. Dimić, Edina H. Avdović, Zoran S. Marković
106 [GO] 2020―Sep―18 Carotane sesquiterpenes from Ferula vesceritensis: in silico analysis as SARS-CoV-2 binding inhibitors Tarik A. Mohamed, Abdelsamed I. Elshamy, Mahmoud A. A. Ibrahim, Ammar Zellagui, Mahmoud F. Moustafa, Alaa H. M. Abdelrahman, et al. (+3)
107 [GO] 2020―Sep―15 Quinazoline-Schiff base conjugates: in silico study and ADMET predictions as multi-target inhibitors of coronavirus (SARS-CoV-2) proteins Mostafa A. Mansour, Asmaa M. AboulMagd, Hamdy M. Abdel-Rahman
108 [GO] 2020―Sep―15 Automated multiplex nucleic acid tests for rapid detection of SARS-CoV-2, influenza A and B infection with direct reverse-transcription quantitative PCR (dirRT-qPCR) assay in a centrifugal microfluidic platform Minghui Ji, Yun Xia, Jacky Fong-Chuen Loo, Lang Li, Ho-Pui Ho, Jianan He, Dayong Gu
109 [GO] 2020―Sep―04 Development of a tablet PC-based portable device for colorimetric determination of assays including COVID-19 and other pathogenic microorganisms Woo Sik Yoo, Hyung Soo Han, Jung Gon Kim, Kitaek Kang, Hyo-Sung Jeon, Jin-Young Moon, Hyeonmi Park
110 [GO] 2020―Aug―28 Inhibition of SARS-CoV-2 main protease by phenolic compounds from Manilkara hexandra (Roxb.) Dubard assisted by metabolite profiling and in silico virtual screening Fatma M. Abd El-Mordy, Mohamed M. El-Hamouly, Magda T. Ibrahim, Gehad Abd El-Rheem, Omar M. Aly, Adel M. Abd El-kader, et al. (+2)
111 [GO] 2020―Aug―28 Rapid prediction of possible inhibitors for SARS-CoV-2 main protease using docking and FPL simulations Minh Quan Pham, Khanh B. Vu, T. Ngoc Han Pham, Le Thi Thuy Huong, Linh Hoang Tran, Nguyen Thanh Tung, et al. (+3)
112 [GO] 2020―Aug―25 Curcumin to inhibit binding of spike glycoprotein to ACE2 receptors: computational modelling, simulations, and ADMET studies to explore curcuminoids against novel SARS-CoV-2 targets Dhivya Shanmugarajan, Prabitha P., B. R. Prashantha Kumar, B. Suresh
113 [GO] 2020―Aug―21 A density functional theory study on silver and bis-silver complexes with lighter tetrylene: are silver and bis-silver carbenes candidates for SARS-CoV-2 inhibition? Insight from molecular docking simulation Thanh Q. Bui, Huynh Thi Phuong Loan, Tran Thi Ai My, Duong Tuan Quang, Bui Thi Phuong Thuy, Vo Duy Nhan, et al. (+6)
114 [GO] 2020―Aug―13 An in silico perception for newly isolated flavonoids from peach fruit as privileged avenue for a countermeasure outbreak of COVID-19 Ahmed E. Allam, Hamdy K. Assaf, Heba Ali Hassan, Kuniyoshi Shimizu, Yaseen A. M. M. Elshaier
115 [GO] 2020―Aug―13 Understanding the role of galectin inhibitors as potential candidates for SARS-CoV-2 spike protein: in silico studies Aaftaab Sethi, Swetha Sanam, Sharon Munagalasetty, Sivaraman Jayanthi, Mallika Alvala
116 [GO] 2020―Jul―29 Targeting severe acute respiratory syndrome-coronavirus (SARS-CoV-1) with structurally diverse inhibitors: a comprehensive review Maryam S. Hosseini-Zare, Ramasamy Thilagavathi, Chelliah Selvam
117 [GO] 2020―Jul―28 A facile assay for rapid detection of COVID-19 antibodies Caixia Liu, Baiping Mao, Vanessa Martinez, Xiaojian Chen, Yanan Li, Lingyun He, et al. (+9)
118 [GO] 2020―Jul―28 An overview of key potential therapeutic strategies for combat in the COVID-19 battle Gaurav Das, Surojit Ghosh, Shubham Garg, Satyajit Ghosh, Aniket Jana, Ramkamal Samat, et al. (+3)
119 [GO] 2020―Jul―27 Potential role of medicinal plants and their constituents in the mitigation of SARS-CoV-2: identifying related therapeutic targets using network pharmacology and molecular docking analyses Eman Shawky, Ahmed A. Nada, Reham S. Ibrahim
120 [GO] 2020―Jul―17 Potential repurposed SARS-CoV-2 (COVID-19) infection drugs Gamal El-Din A. Abuo-Rahma, Mamdouh F. A. Mohamed, Tarek S. Ibrahim, Mai E. Shoman, Ebtihal Samir, Rehab M. Abd El-Baky
121 [GO] 2020―Jul―17 Remdesivir-bound and ligand-free simulations reveal the probable mechanism of inhibiting the RNA dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2 Shruti Koulgi, Vinod Jani, Mallikarjunachari V. N. Uppuladinne, Uddhavesh Sonavane, Rajendra Joshi
122 [GO] 2020―Jul―01 Consensus virtual screening of dark chemical matter and food chemicals uncover potential inhibitors of SARS-CoV-2 main protease Marisa G. Santibáñez-Morán, Edgar López-López, Fernando D. Prieto-Martínez, Norberto Sánchez-Cruz, José L. Medina-Franco
123 [GO] 2020―Jun―19 Natural products' role against COVID-19 Ananda da Silva Antonio, Larissa Silveira Moreira Wiedemann, Valdir Florêncio Veiga-Junior
124 [GO] 2020―Jun―15 Ursolic acid derivatives are potent inhibitors against porcine reproductive and respiratory syndrome virus Yang Chen, Hui Li, Li Wu, Mingxin Zhang, Yarou Gao, Heng Wang, et al. (+4)
125 [GO] 2020―May―21 Molecular docking reveals the potential of Salvadora persica flavonoids to inhibit COVID-19 virus main protease Asmaa I. Owis, Marwa S. El-Hawary, Dalia El Amir, Omar M. Aly, Usama Ramadan Abdelmohsen, Mohamed S. Kamel
126 [GO] 2020―Apr―21 Anti-HIV drug repurposing against SARS-CoV-2 Peng Sang, Shu-Hui Tian, Zhao-Hui Meng, Li-Quan Yang
127 [GO] 2020―Apr―07 High antiviral activity of mercaptoethane sulfonate functionalized Te/BSA nanostars against arterivirus and coronavirus Yanrong Zhou, Xiaohan Jiang, Ting Tong, Liurong Fang, Yuan Wu, Jiangong Liang, Shaobo Xiao
 [1] 

127 Results       Page 1


[de][en]

Last change 2023―Apr―13 19:50:14 UTC

© Daten-Quadrat 2022       Done in 0.007 sec